Aigen Investment Management, LP Nektar Therapeutics Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$4.16 - $13.72 $50,144 - $165,380	-12,054 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$10.83 - $18.41 $130,544 - $221,914	12,054 New	12,054 $146,000
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $334,497 - $403,645	-21,211 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$16.59 - $24.79 $949,611 - $1.42 Million	-57,240 Reduced 72.96%	21,211 $352,000
Q2 2020 Aug 10, 2020	BUY	$16.86 - $23.44 $1.26 Million - $1.75 Million	74,845 Added 2075.57%	78,451 $1.82 Million

Q1 2020 May 08, 2020	BUY	$14.47 - $27.96 $52,178 - $100,823	3,606 New	3,606 $64,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.